These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20626115)

  • 21. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies.
    Hanet MS; Jamart J; Chaves AP
    Can J Ophthalmol; 2012 Dec; 47(6):493-9. PubMed ID: 23217502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
    Jensen H; Zerouala C; Carrier M; Short B
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LASIK infectious keratitis.
    Das M; Garg P
    Ophthalmology; 2011 Feb; 118(2):425; author reply 425.e1. PubMed ID: 21292114
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis, laboratory analysis, and treatment of bacterial corneal ulcers.
    Stonecipher KG; Jensen H
    Optom Clin; 1995; 4(3):53-64. PubMed ID: 7767019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological treatment for infectious corneal ulcers.
    Miller D
    Expert Opin Pharmacother; 2013 Apr; 14(5):543-60. PubMed ID: 23441746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of chloramphenicol use and the effect on corneal scrape results in bacterial keratitis.
    Pearce F; Wong N; Chan E
    Clin Exp Ophthalmol; 2016 Dec; 44(9):868-869. PubMed ID: 27549348
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis.
    Wilhelmus KR; Abshire RL; Schlech BA
    Arch Ophthalmol; 2003 Sep; 121(9):1229-33. PubMed ID: 12963604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of bacterial corneal ulcers at tertiary centres in Vancouver, B.C.
    Termote K; Joe AW; Butler AL; McCarthy M; Blondeau JM; Iovieno A; Holland SP; Yeung SN
    Can J Ophthalmol; 2018 Aug; 53(4):330-336. PubMed ID: 30119785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a New Matrix Therapy Agent in Persistent Epithelial Defects After Bacterial Keratitis Treated With Topical Fortified Antibiotics.
    Chappelet MA; Bernheim D; Chiquet C; Aptel F
    Cornea; 2017 Sep; 36(9):1061-1068. PubMed ID: 28691943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shifting trends in bacterial keratitis in Toronto: an 11-year review.
    Lichtinger A; Yeung SN; Kim P; Amiran MD; Iovieno A; Elbaz U; Ku JY; Wolff R; Rootman DS; Slomovic AR
    Ophthalmology; 2012 Sep; 119(9):1785-90. PubMed ID: 22627118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectious keratitis in 204 586 LASIK procedures.
    Llovet F; de Rojas V; Interlandi E; Martín C; Cobo-Soriano R; Ortega-Usobiaga J; Baviera J
    Ophthalmology; 2010 Feb; 117(2):232-8.e1-4. PubMed ID: 20006909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic resistance in microbial keratitis: ten-year experience of corneal scrapes in the United Kingdom.
    Shalchi Z; Gurbaxani A; Baker M; Nash J
    Ophthalmology; 2011 Nov; 118(11):2161-5. PubMed ID: 21764458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conrad Berens Lecture. The management of infectious keratitis as we approach the 21st century.
    Forster RK
    CLAO J; 1998 Jul; 24(3):175-80. PubMed ID: 9684077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbial keratitis at extremes of age.
    Parmar P; Salman A; Kalavathy CM; Kaliamurthy J; Thomas PA; Jesudasan CA
    Cornea; 2006 Feb; 25(2):153-8. PubMed ID: 16371773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of sparfloxacin eye drop in the management of conjunctival and corneal infection.
    Vyas U; Desai T; Shah C
    J Indian Med Assoc; 2002 Jun; 100(6):398-9. PubMed ID: 12416674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resisting susceptibility: bacterial keratitis and generations of antibiotics.
    McGhee CN; Niederer R
    Clin Exp Ophthalmol; 2006; 34(1):3-5. PubMed ID: 16451250
    [No Abstract]   [Full Text] [Related]  

  • 37. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
    Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial.
    See CW; Srinivasan M; Saravanan S; Oldenburg CE; Esterberg EJ; Ray KJ; Glaser TS; Tu EY; Zegans ME; McLeod SD; Acharya NR; Lietman TM
    Ophthalmic Epidemiol; 2012 Dec; 19(6):407-13. PubMed ID: 23171211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
    Goldstein MH; Kowalski RP; Gordon YJ
    Ophthalmology; 1999 Jul; 106(7):1313-8. PubMed ID: 10406613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.